110 related articles for article (PubMed ID: 20067910)
1. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure.
Loureiro J; Schilte M; Aguilera A; Albar-Vizcaíno P; Ramírez-Huesca M; Pérez-Lozano ML; González-Mateo G; Aroeira LS; Selgas R; Mendoza L; Ortiz A; Ruíz-Ortega M; van den Born J; Beelen RH; López-Cabrera M
Nephrol Dial Transplant; 2010 Apr; 25(4):1098-108. PubMed ID: 20067910
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
Shentu Y; Li Y; Xie S; Jiang H; Sun S; Lin R; Chen C; Bai Y; Zhang Y; Zheng C; Zhou Y
Int Immunopharmacol; 2021 Apr; 93():107374. PubMed ID: 33517222
[TBL] [Abstract][Full Text] [Related]
3. Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells.
Shi SS; Zhang YQ; Zhang LQ; Li YF; Zhou XS; Li RS
Int Urol Nephrol; 2024 Mar; ():. PubMed ID: 38483736
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen Alleviates Endometrial Fibrosis Induced by Anhydrous Ethanol in Rats.
Jiang H; Song J; Yang M; He X; Wang H; Deng X
Discov Med; 2024 Jan; 36(180):160-172. PubMed ID: 38273756
[TBL] [Abstract][Full Text] [Related]
5. Effects of sitagliptin on peritoneal membrane: The potential role of mesothelial cell tight junction proteins.
Jo CH; Kim S; Ha TK; Kang DH; Kim GH
Perit Dial Int; 2023 Nov; 43(6):448-456. PubMed ID: 36998201
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C inhibits mesothelial-to-mesenchymal transition in experimental peritoneal fibrosis.
Giri H; Biswas I; Rezaie AR
J Thromb Haemost; 2023 Jan; 21(1):133-144. PubMed ID: 36695376
[TBL] [Abstract][Full Text] [Related]
7. Fibrin-Induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline.
Fang CC; Huang JW; Shyu RS; Yen CJ; Shiao CH; Chiang CK; Hu RH; Tsai TJ
PLoS One; 2012; 7(9):e44765. PubMed ID: 23028611
[TBL] [Abstract][Full Text] [Related]
8. Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer.
Wang C; Ji J; Jin Y; Sun Y; Cai Q; Jiang J; Guo L; Zhou C; Zhang J
Oncogene; 2024 Jan; 43(3):171-188. PubMed ID: 37989866
[TBL] [Abstract][Full Text] [Related]
9. Brahma-related gene 1 acts as a profibrotic mediator and targeting it by micheliolide ameliorates peritoneal fibrosis.
Li S; Luo C; Chen S; Zhuang Y; Ji Y; Zeng Y; Zeng Y; He X; Xiao J; Wang H; Chen X; Long H; Peng F
J Transl Med; 2023 Sep; 21(1):639. PubMed ID: 37726857
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes.
Szebeni B; Veres-Székely A; Pap D; Bokrossy P; Varga Z; Gaál A; Mihály J; Pállinger É; Takács IM; Pajtók C; Bernáth M; Reusz GS; Szabó AJ; Vannay Á
Cells; 2024 Mar; 13(7):. PubMed ID: 38607044
[TBL] [Abstract][Full Text] [Related]
11. Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis.
Sun Y; Zhu F; Yu X; Nie J; Huang F; Li X; Luo N; Lan HY; Wang Y
Am J Nephrol; 2009; 30(1):84-94. PubMed ID: 19223683
[TBL] [Abstract][Full Text] [Related]
12. Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis.
Liu F; Yu C; Qin H; Zhang S; Fang L; Wang Y; Wang J; Cui B; Hu S; Liu N; Zhuang S
J Cell Mol Med; 2021 May; 25(13):6103-14. PubMed ID: 33949772
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage.
Lee YC; Huang CT; Cheng FY; Hung SY; Lin TM; Tsai YC; Chen CI; Wang HK; Lin CW; Liou HH; Chang MY; Wang HH; Chiou YY
Int J Nanomedicine; 2019; 14():9665-9675. PubMed ID: 31824158
[TBL] [Abstract][Full Text] [Related]
14. Biological Effects of XyloCore, a Glucose Sparing PD Solution, on Mesothelial Cells: Focus on Mesothelial-Mesenchymal Transition, Inflammation and Angiogenesis.
Masola V; Bonomini M; Onisto M; Ferraro PM; Arduini A; Gambaro G
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209455
[TBL] [Abstract][Full Text] [Related]
15. Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-
Duan Z; Yao J; Duan N; Wang M; Wang S
Evid Based Complement Alternat Med; 2021; 2021():2052787. PubMed ID: 34497655
[TBL] [Abstract][Full Text] [Related]
16. Novel Peritoneal Sclerosis Rat Model Developed by Administration of Bleomycin and Lansoprazole.
Kunitatsu K; Yamamoto Y; Nasu S; Taniji A; Kawashima S; Yamagishi N; Ito T; Inoue S; Kanai Y
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003303
[TBL] [Abstract][Full Text] [Related]
17. Telomere length profiles in primary human peritoneal mesothelial cells are consistent with senescence.
Lopez-Anton M; Rudolf A; Baird DM; Roger L; Jones RE; Witowski J; Fraser DJ; Bowen T
Mech Ageing Dev; 2017 Jun; 164():37-40. PubMed ID: 28373051
[TBL] [Abstract][Full Text] [Related]
18. The consistent anti-cancer effect of a simple exercise (Ou MC decrescendo phenomenon exercise) may hold promise for low-cost cancer prevention.
Ou MC; Chen FM
Ann Med Surg (Lond); 2024 Apr; 86(4):2137-2142. PubMed ID: 38576944
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic targets and peritoneal membrane remodeling.
Farhat K; Stavenuiter AW; Beelen RH; Ter Wee PM
Perit Dial Int; 2014; 34(1):114-23. PubMed ID: 24525599
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Mesothelial Cell Fate during Development and Human Diseases.
Taniguchi T; Tomita H; Kanayama T; Mogi K; Koya Y; Yamakita Y; Yoshihara M; Kajiyama H; Hara A
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
